RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

This recall is currently active, issued January 15, 2025. It was issued by Rising Pharma Holding, Inc..

Company
Rising Pharma Holding, Inc.
Recall Initiated
December 30, 2024
Posted
January 15, 2025
Recall Number
D-0189-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
73,680 bottles
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Distribution

Nationwide

Lot / Code Info

Lot # DT2023003A, DT2023007A, DT2023008A, exp. date Jan-25

More recalls by Rising Pharma Holding, Inc.

View all recalls by this company →

Other recent Class II Drug recalls